buprenorphine

Manufacturer: PAYLESS COMPOUNDERS, LLC
Effective date: 2015-10-29
Label type: ANIMAL COMPOUNDED DRUG LABEL
Version: 3
Source: full-release
Hydrated at: 2026-06-01 02:48:08

Label at a glance#

Productbuprenorphine

Active ingredientBUPRENORPHINE HYDROCHLORIDE

Label structure1 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
238129	buprenorphine HCl 0.3 MG in 1 ML Injection	PSN	3
238129	1 ML buprenorphine 0.3 MG/ML Injection	SCD	3
238129	buprenorphine 0.3 MG/ML (as buprenorphine HCl 0.324 MG/ML) Injection	SY	3
238129	buprenorphine HCl 0.3 MG per 1 ML Injection	SY	3

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
BUPRENORPHINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
68654759-f50b-79ef-24c5-544d94fe7d87	Product name	3	20251114
08a295bb-88df-4ab0-a120-a75a789a74f1	Product name	1	20231013
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
ab841ac7-728a-4fc9-be0a-35b96cecbf39	Product name	4	20230306
100316cc-94a9-474e-97ad-9b5c6ddec605	Product name	5	20230125
539bc5d3-546b-4af6-9c31-058ce6c459d3	Product name	2	20220210
b871fccd-1de6-4c7f-b9e5-045304641ee6	Product name	8	20220118
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
31e16ab2-c562-4617-a3e8-ed285320e16e	Product name	1	20180201
4c23a34c-e8fc-424c-8fa0-ee064ba6eaef	Product name	1	20170706
a5920611-4285-f024-69b9-39ff338b81ea	Product name	5	20170609
3df867ed-9d48-45cf-bded-1394beaea0b1	Product name	3	20161206
973da5bf-b1f9-4de0-81ee-7ca066c98ca4	Product name	1	20160712
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70022-001-10	buprenorphine	10 mL in 1 VIAL, MULTI-DOSE	INJECTION, SOLUTION	10		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70022-001	BUPRENORPHINE INJECTION, SOLUTION [PAYLESS COMPOUNDERS, LLC]	3	1 package rows	20151030_7fc0c3fd-5122-43ce-995d-a55a7ea02371.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BUPRENORPHINE HYDROCHLORIDE	ACTIVE INGREDIENT	56W8MW3EN1	3
BUPRENORPHINE	ACTIVE MOIETY	40D3SCR4GZ	3
ANHYDROUS DEXTROSE	INACTIVE INGREDIENT	5SL0G7R0OK	3
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	3
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	3
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

buprenorphine
BUPRENORPHINE HYDROCHLORIDE
ANHYDROUS DEXTROSE
MANNITOL
WATER
HYDROCHLORIC ACID
BENZYL ALCOHOL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
70022-001	70022-001-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BUPRENORPHINE HYDROCHLORIDE	56W8MW3EN1	ACTIM
ANHYDROUS DEXTROSE	5SL0G7R0OK	IACT
MANNITOL	3OWL53L36A	IACT
WATER	059QF0KO0R	IACT
HYDROCHLORIC ACID	QTT17582CB	IACT
BENZYL ALCOHOL	LKG8494WBH	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 277 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
ANHYDROUS DEXTROSE	ANHYDROUS DEXTROSE	5SL0G7R0OK	INJECTION / SUBCUTANEOUS	7.5 %w/v		Exact identifier — unii candidate 14 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION/ DROPS / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION, CONCENTRATE / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, FOR SUSPENSION / ORAL		7621 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION / INTRAVITREAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SOLUTION / INTRAVESICAL		157 mg	Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION/ DROPS / TOPICAL	0.3 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER, FOR SUSPENSION / ORAL		7093 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SOLUTION / SUBMUCOSAL	2.94 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 65 equally ranked IID candidates
ANHYDROUS DEXTROSE	ANHYDROUS DEXTROSE	5SL0G7R0OK	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	3.9 %w/v		Exact identifier — unii candidate 14 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	GRANULE, FOR SUSPENSION / ORAL		6000 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / URETERAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	POWDER / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, CHEWABLE / ORAL		3726 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / INTRAVENOUS		15400 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, EMULSION / INTRAMUSCULAR		225 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / TOPICAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / SUBCUTANEOUS	4.54 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, FOR SOLUTION / INTRADERMAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRALESIONAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	CONCENTRATE / ORAL	2.17 mg/1ml		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE, EXTENDED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	980.4 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SHAMPOO / TOPICAL		104 mg	Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SUSPENSION / AURICULAR (OTIC)	0.04 %w/v		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION / INTRAVENOUS		15200 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	LIQUID / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SUSPENSION / INTRAVENOUS	2.5 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	LOZENGE / ORAL		20546 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SUSPENSION/ DROPS / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION / OPHTHALMIC		9 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	LOTION / TOPICAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	GUM, CHEWING / BUCCAL		891 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRABURSAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / TOPICAL	1 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	POWDER, FOR SUSPENSION / ORAL		125 mg	Exact identifier — unii candidate 148 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRAVENOUS		1620 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION / INTRALESIONAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	AEROSOL, METERED / RESPIRATORY (INHALATION)	0.7 %w/w		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	DROPS / NASAL	10 ml		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / OPHTHALMIC	4.7 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRACARDIAC	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
ANHYDROUS DEXTROSE	ANHYDROUS DEXTROSE	5SL0G7R0OK	INJECTION / INTRAVENOUS		36000 mg	Exact identifier — unii candidate 14 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	GEL / TOPICAL		10 mg	Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTABLE, LIPOSOMAL / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / NASAL	91.7 mg/100ml		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRAVITREAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / IRRIGATION	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		543 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / ORAL		100 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	EMULSION / TOPICAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 36 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
buprenorphine hydrochloride	BUPRENORPHINE HYDROCHLORIDE	Advagen Pharma Ltd	699638dd-3a53-445f-a545-d0e6eabfe1c9	2026-07-17	Warnings, Adverse reactions	Name fallback generic name: BUPRENORPHINE HYDROCHLORIDE
Buprenorphine	BUPRENORPHINE	REMEDYREPACK INC.	aa86a438-1ebf-4c08-bf27-38f1e81efb3a	2026-07-07	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
buprenorphine hydrochloride	BUPRENORPHINE HYDROCHLORIDE	REMEDYREPACK INC.	11686845-f5fd-4e96-8a4f-9b132bf48840	2026-07-07	Warnings, Adverse reactions	Name fallback generic name: BUPRENORPHINE HYDROCHLORIDE
BUPRENORPHINE	BUPRENORPHINE	Unit Dose Solutions, Inc.	5578cd5c-c860-6e8a-e063-6394a90a56c7	2026-06-30	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
BUPRENORPHINE	BUPRENORPHINE	Bryant Ranch Prepack	aa132031-9d12-45b4-81e0-4a5877661379	2026-06-29	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
Buprenorphine	BUPRENORPHINE	Bryant Ranch Prepack	655e3e52-03be-496c-978a-5cffc74b2ae4	2026-06-29	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	Unit Dose Solutions, Inc.	5479b218-a388-2c3c-e063-6294a90a0e85	2026-06-17	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
BUPRENORPHINE	BUPRENORPHINE	Bryant Ranch Prepack	966adb01-71b4-4e0b-bbc6-b83da9987aa2	2026-06-16	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
Buprenorphine	BUPRENORPHINE	Major Pharmaceuticals	dba586f9-e3f2-4b9c-849b-907c81a5a0ef	2026-06-16	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	Bryant Ranch Prepack	bc5a7137-9e8f-438e-84d9-bdbf1db12998	2026-06-03	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
Buprenorphine	BUPRENORPHINE	Rhodes Pharmaceuticals LLC	2738feae-316e-426f-971c-5f142ac01b60	2026-05-29	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
Buprenorphine	BUPRENORPHINE	Actavis Pharma, Inc.	03819118-86f6-4329-adaf-4599e7b71f46	2026-05-25	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
Buprenorphine	BUPRENORPHINE	Teva Pharmaceuticals USA, Inc.	36995ce3-b515-447b-baa9-aa14f84060d8	2026-05-12	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	Rhodes Pharmaceuticals LLC	da90618a-5621-4b15-bc48-9dcc631418de	2026-05-04	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
Buprenorphine	BUPRENORPHINE	INGENUS PHARMACEUTICALS, LLC	186e3be6-8bc0-4bb9-96f5-429d53632f45	2026-04-28	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
Buprenorphine	BUPRENORPHINE	Aveva Drug Delivery Systems Inc.	1aae9b13-7431-42ef-8558-14a2325820e6	2026-04-28	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	Bryant Ranch Prepack	cd0a90c6-32cc-4114-8573-86ac85503bdf	2026-04-03	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
buprenorphine hydrochloride	BUPRENORPHINE HYDROCHLORIDE	PAI Holdings, LLC dba PAI Pharma	442831cf-9636-433a-9a12-e9a8cd31f72a	2026-02-28	Warnings, Adverse reactions	Name fallback generic name: BUPRENORPHINE HYDROCHLORIDE
Buprenorphine	BUPRENORPHINE	Sun Pharmaceutical Industries, Inc.	9fd1f18f-0b0f-4059-b603-19ecbf0ed63a	2026-02-11	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	A-S Medication Solutions	bfb02ea5-22f2-432e-afc8-f1dbe2ea0614	2026-02-06	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.